1. Home
  2. SHPH vs GNLN Comparison

SHPH vs GNLN Comparison

Compare SHPH & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • GNLN
  • Stock Information
  • Founded
  • SHPH 2012
  • GNLN 2005
  • Country
  • SHPH United States
  • GNLN United States
  • Employees
  • SHPH N/A
  • GNLN N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • GNLN Durable Goods
  • Sector
  • SHPH Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • SHPH Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • SHPH 2.3M
  • GNLN 2.0M
  • IPO Year
  • SHPH 2022
  • GNLN 2019
  • Fundamental
  • Price
  • SHPH $0.22
  • GNLN $0.01
  • Analyst Decision
  • SHPH
  • GNLN
  • Analyst Count
  • SHPH 0
  • GNLN 0
  • Target Price
  • SHPH N/A
  • GNLN N/A
  • AVG Volume (30 Days)
  • SHPH 12.3M
  • GNLN 270.8M
  • Earning Date
  • SHPH 05-08-2025
  • GNLN 05-15-2025
  • Dividend Yield
  • SHPH N/A
  • GNLN N/A
  • EPS Growth
  • SHPH N/A
  • GNLN N/A
  • EPS
  • SHPH N/A
  • GNLN N/A
  • Revenue
  • SHPH N/A
  • GNLN $13,275,000.00
  • Revenue This Year
  • SHPH N/A
  • GNLN $1,541.21
  • Revenue Next Year
  • SHPH N/A
  • GNLN N/A
  • P/E Ratio
  • SHPH N/A
  • GNLN N/A
  • Revenue Growth
  • SHPH N/A
  • GNLN N/A
  • 52 Week Low
  • SHPH $0.23
  • GNLN $0.01
  • 52 Week High
  • SHPH $4.71
  • GNLN $21.80
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 33.61
  • GNLN 19.03
  • Support Level
  • SHPH $0.20
  • GNLN $0.01
  • Resistance Level
  • SHPH $0.27
  • GNLN $0.01
  • Average True Range (ATR)
  • SHPH 0.04
  • GNLN 0.00
  • MACD
  • SHPH 0.00
  • GNLN 0.01
  • Stochastic Oscillator
  • SHPH 6.02
  • GNLN 15.00

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: